Pentavalent Market Growth Outlook Through 2024-2033

Overview and Scope
Pentavalent refers to a vaccine that protects a child from life-threatening diseases. This vaccine is used to protect infants and young children from rotavirus infection. Rotavirus infection can result in fever, vomiting, and diarrhea.

Sizing and Forecast
The pentavalent market size has grown steadily in recent years. It will grow from $2.53 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to global immunization initiatives, government vaccination programs, prevention of multiple diseases, public health awareness, international partnerships and funding.

The pentavalent market size is expected to see steady growth in the next few years. It will grow to $3.17 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to continued global immunization efforts, expansion of vaccination programs, introduction in new geographies, research and development initiatives, collaborations for vaccine access. Major trends in the forecast period include global health initiatives and funding support, public awareness and education campaigns, government policies and regulatory frameworks, technological innovations in vaccine manufacturing.

Order your report now for swift delivery, visit the link:
https://thebusinessresearchcompany.com/report/pentavalent-global-market-report

Segmentation & Regional Insights
The pentavalent market covered in this report is segmented –

1) By Type: Sodium Stibogluconate, Meglumine Antimoniate
2) By Formulation Type: Lyophilized, Liquid
3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Asia-Pacific was the largest region in the pentavalent market in 2023. The regions covered in the pentavalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=9104&type=smp

Major Driver Impacting Market Growth
The rising prevalence of diphtheria is expected to boost the growth of the pentavalent market going forward. Corynebacterium diphtheriae is a bacterium that causes the severe, extremely contagious disease known as diphtheria. Diphtheria causes severe difficulties with eating and breathing, as well as the possibility of skin ulcers. The pentavalent vaccine protects children from Diphtheria diseases by a pentavalent immunization in a 3-dose schedule, as a result, the rising prevalence of diphtheria increased the demand for pentavalent vaccines. For instance, in 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, an unusually high number of reported cases of diphtheria were recorded through the International Health Regulations (IHR) reporting process, primarily in the months of June and August 2022. Seven nations have documented 144 instances of diphtheria, many of which were among asylum seekers. Among 144 patients, 97 (69%) were determined to be clinically compatible, 44 (31%) to be toxigenic diphtheria cases by laboratory confirmation, and 3 (2%) were suspected cases. Therefore, the rising prevalence of diphtheria is driving the growth of the pentavalent market.

Key Industry Players

Major companies operating in the pentavalent market report are Pfizer Inc., Merck & Co Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, LG Chem Ltd., GlaxoSmithKline PLC, Shandong Xinhua Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, PT Bio Farma (Persero), Shantha Biotechnics Limited, Seqirus Holdings PLC, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, Biogenics Pvt Ltd., GreenSignal Bio Pharma Limited, PanGen Biotech Inc., Biomed Pvt Ltd., Maiden Pharmaceuticals Limited, Panacea Drugs Limited, Crucell N.V., Bharat Biotech International Limited, Vacsera Ltd., Vacunas Finlay S.A., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

The pentavalent market report table of contents includes:

1. Executive Summary
2. Pentavalent Market Characteristics
3. Pentavalent Market Trends And Strategies
4. Pentavalent Market – Macro Economic Scenario
5. Global Pentavalent Market Size and Growth
.
.
.
31. Pentavalent Market Other Major And Innovative Companies
32. Global Pentavalent Market Competitive Benchmarking
33. Global Pentavalent Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Pentavalent Market
35. Pentavalent Market Future Outlook and Potential Analysis
36.Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model